Julie Stout is a Professor in the School of Psychological Sciences at Monash University. She leads a team of post-docs, students, and IT specialists, employing techniques from neuropsychology and cognitive neuroscience to characterise the effects of neurodegeneration on cognition and brain function. Her research group is known for innovations in assessments using computerised and sensor-based approaches.  

Professor Stout is a leading international expert in Huntington’s Disease. Her team has led the cognitive component of several large, international studies, which have described the cognitive, motor, psychiatric, and brain imaging changes in people with the Huntington’s Disease gene as they progress from normal functioning to manifest Huntington’s Disease. Professor Stout also led a 20-site international study that yielded the HD-CAB, which is now the standard cognitive assessment battery for clinical trials in Huntington’s Disease. Professor Stout also co-leads the Scientific Planning Committee of Enroll-HD, the largest ever study of people from Huntington’s Disease families, which has over 12,000 participants globally. A key translation of Professor Stout’s research is that the diagnosis of Huntington’s Disease is now being refined to take into account, for the first time, cognitive changes rather than focusing exclusively on the movement disorder symptoms.

In Australia, Julie leads the Huntington’s Disease Network of Australia (HDNA), with funding from the NHMRC via an Investigator Grant. The HDNA, through a team of researchers at Monash University and in collaboration with nationally representative stakeholders, has developed and implemented the Map-HD Registry, which is Australia’s first ever registry for people with HD and their carers. The HDNA is also conducting a prevalence study of HD in Australia and is looking at a model of care for the Australian context. The HDNA is also developing a clinical trials network, and addressing preparations needed to be able to rapidly deploy new treatments in Australia once they are identified in global clinical trials.

Professor Stout is Director of Zindametrix Pty Ltd., which is a company that provides an assessment platform and services for cognitive assessment in clinical trials to pharmaceutical sponsors. Her team collaborates with multiple industry partners, pushing innovation by integrating emerging technologies such as mobile devices and sensors into clinical trials, with the aim of capturing individual differences in both disease phenotypes and responsivity to treatments. 

Clinical Research Psychologist, Department of Veterans' Affairs Medical Center, San Diego, California, 1992-1995

Post-doctoral Fellow, Brain Image Analysis Laboratory, Department of Psychiatry, University of California, San Diego, California, 1992-1994

Assistant Project Scientist, Brain Image Analysis Laboratory, Department of Psychiatry, University of California, San Diego, California, 1994-1995

Director, Clinical and Cognitive Neuroscience Laboratory, Indiana University, 1995-2009

Assistant Professor, Department of Psychology, Programs in Neural Science and Cognitive Science, Indiana University, Bloomington, Indiana, 1995-2003

Adjunct Assistant Professor of Clinical Psychology, Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, 1995-2003

Associate Professor, Department of Psychology, Programs in Neural Science, Clinical Science and Cognitive Science, Indiana University, Bloomington, Indiana, 2003-2007

Adjunct Associate Professor of Clinical Psychology, Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, 2003-2007

Director, Imaging Research Facility, Indiana University, Bloomington, Indiana, 2005-2007.

Professor, Department of Psychological and Brain Sciences, Programs in Neural Science, Clinical Science and Cognitive Science, Indiana University, Bloomington, Indiana, 2007-2009

Professor, School of Psychology, Psychiatry, and Psychological Medicine, Monash University, 2007-present

Director, Clinical Cognitive Neuroscience Laboratory, Monash University, 2007 - present

Current or previous consultant to:

Eli Lilly and Co., Prana Biotechnology Ltd, GSK PLC, Roche, Teva Pharmaceuticals

PSY1011 Psychology 1A
PSY2031 Developmental and biological psychology
PSY2042 Cognitive and social psychology
PSY4270 Psychological assessment

DPSY5162 Neuroanatomy for the clinical neuropsychologist
DPSY5261 Neuropsychological models of cognition and behaviour part 1